Literature DB >> 24238575

Quality assurance for care of melanoma patients based on guideline-derived quality indicators and certification.

Markus Follmann1, Dirk Schadendorf, Corinna Kochs, Barbara Buchberger, Anna Winter, Simone Wesselmann.   

Abstract

BACKGROUND AND OBJECTIVES: In 2013 the first German S-3 guidelines on the diagnosis, treatment, and follow-up of melanoma were published in the framework of the German Guideline Program on Oncology. Quality indicators were developed at the same time as the guideline development process in order to implement the guideline recommendations. PATIENTS AND METHODS: A multidisciplinary, interprofessional working group developed quality indicators following a standardized process.
RESULTS: Twelve quality indicators directly linked to guideline recommendations were generated and agreed on by consensus. They were integrated into the catalogue of requirements for dermato-oncological centers certified by the German Cancer Society.
CONCLUSIONS: The close cooperation between the guideline group and commission for certification allowed the guideline contents to be implemented in the form of quality indicators in everyday clinical practice. Adherence to the guidelines is required and continuously evaluated as part of certification.
© 2014 Deutsche Dermatologische Gesellschaft (DDG). Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2013        PMID: 24238575     DOI: 10.1111/ddg.12238

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN: 1610-0379            Impact factor:   5.584


  4 in total

1.  Quality assessment in prostate cancer centers certified by the German Cancer Society.

Authors:  Christoph Kowalski; Julia Ferencz; Peter Albers; Jan Fichtner; Thomas Wiegel; Günter Feick; Simone Wesselmann
Journal:  World J Urol       Date:  2015-09-21       Impact factor: 4.226

2.  International experiences in the development and implementation of guideline-based quality indicators: a qualitative study.

Authors:  Monika Nothacker; Marie Bolster; Mirco Steudtner; Katrin Arnold; Stefanie Deckert; Monika Becker; Ina Kopp; Jochen Schmitt
Journal:  BMJ Open       Date:  2021-01-19       Impact factor: 2.692

3.  Clinical performance indicators for monitoring the management of cutaneous melanoma: a population-based perspective.

Authors:  Alessandra Buja; Massimo Rugge; Giuseppe De Luca; Manuel Zorzi; Claudia Cozzolino; Antonella Vecchiato; Paolo Del Fiore; Saveria Tropea; Alberto Bortolami; Patrizia Benini; Carlo Riccardo Rossi; Simone Mocellin
Journal:  Melanoma Res       Date:  2022-07-19       Impact factor: 3.199

4.  Quality indicators for responsible use of medicines: a systematic review.

Authors:  Kenji Fujita; Rebekah J Moles; Timothy F Chen
Journal:  BMJ Open       Date:  2018-07-16       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.